Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CASIRIVIMAB\IMDEVIMAB Cause Atrioventricular block first degree? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Atrioventricular block first degree have been filed in association with CASIRIVIMAB\IMDEVIMAB. This represents 0.1% of all adverse event reports for CASIRIVIMAB\IMDEVIMAB.

5
Reports of Atrioventricular block first degree with CASIRIVIMAB\IMDEVIMAB
0.1%
of all CASIRIVIMAB\IMDEVIMAB reports
0
Deaths
3
Hospitalizations

How Dangerous Is Atrioventricular block first degree From CASIRIVIMAB\IMDEVIMAB?

Of the 5 reports, 3 (60.0%) required hospitalization.

Is Atrioventricular block first degree Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CASIRIVIMAB\IMDEVIMAB. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does CASIRIVIMAB\IMDEVIMAB Cause?

Infusion related reaction (875) Dyspnoea (687) Nausea (416) Oxygen saturation decreased (390) Dizziness (357) Pyrexia (306) Chest discomfort (294) Chills (265) Flushing (238) Cough (235)

What Other Drugs Cause Atrioventricular block first degree?

FINGOLIMOD (285) AMLODIPINE (148) METOPROLOL (120) BISOPROLOL (98) FLECAINIDE (98) OMEPRAZOLE (94) AMIODARONE (85) VERAPAMIL (84) DILTIAZEM (79) FUROSEMIDE (78)

Which CASIRIVIMAB\IMDEVIMAB Alternatives Have Lower Atrioventricular block first degree Risk?

CASIRIVIMAB\IMDEVIMAB vs CASPOFUNGIN CASIRIVIMAB\IMDEVIMAB vs CATEQUENTINIB CASIRIVIMAB\IMDEVIMAB vs CC-4047 CASIRIVIMAB\IMDEVIMAB vs CEDAZURIDINE\DECITABINE CASIRIVIMAB\IMDEVIMAB vs CEDIRANIB

Related Pages

CASIRIVIMAB\IMDEVIMAB Full Profile All Atrioventricular block first degree Reports All Drugs Causing Atrioventricular block first degree CASIRIVIMAB\IMDEVIMAB Demographics